Skip to main content
. 2013 Feb 21;97(5):617–621. doi: 10.1136/bjophthalmol-2012-302652

Figure 2.

Figure 2

The changes in the mean foveal thickness during the 2-year follow-up period after the first ranibizumab injection to treat polypoidal choroidal vasculopathy in Japanese patients. The numbers in the parentheses indicate 1 SD of the mean.